Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Title: 

ALLOGENEIC FIBROBLASTS IN CELL THERAPY OF WOUND HEALING

Type: POSTER
Author(s): ZARE SONA*,JAHANGIRI FAEZE,NILFOROUSHZADEH MOHAMMAD ALI,VAZINI HOSSEIN,DAHMARDEHEI MOSTAFA,HEJAZI SOMAYEH
 
 *SKIN AND STEM CELL RESEARCH CENTER, TEHRAN UNIVERSITY OF MEDICAL SCIENCES, TEHRAN, IRAN
 
Name of Seminar: CONGRESS OF WOUND AND TISSUE REPAIR
Type of Seminar:  CONGRESS
Sponsor:  MEDICAL SCIENCE ACECR
Date:  2016Volume 3
 
 
Abstract: 

FIBROBLASTS USED IN TISSUE ENGINEERING MAY BE ALLOGENEIC OR AUTOLOGOUS. IN CONTRAST TO ALLOGENEIC CELLS, AUTOLOGOUS FIBROBLASTS CARRY NO RISK OF REJECTION OR RISK OF CROSS-INFECTION. HOWEVER, THERE IS OFTEN A DELAY IN CULTURING AUTOLOGOUS CELLS IN ORDER TO OBTAIN SUFFICIENT CELL NUMBERS, WHEREAS ALLOGENEIC CELLS ARE CRYOPRESERVED AND THEREFORE READILY AVAILABLE. FOR PERMANENT ENGRAFTMENT, AUTOLOGOUS FIBROBLASTS ARE NECESSARY.

 
Keyword(s): ALLOGENEIC, FIBROBLAST, CELL THERAPY, WOUND HEALING
 
 
Yearly Visit 64   pdf-file tarjomyar
 
Latest on Blog
Enter SID Blog